Cubist Systematic Strategies’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.51M | Sell |
82,441
-72,716
| -47% | -$3.63M | 0.02% | 1024 |
|
|
2025
Q2 | $8.25M | Buy |
+155,157
| New | +$7.88M | 0.04% | 717 |
|
|
2024
Q1 | – | Sell |
-3,333
| Closed | -$211K | – | 3884 |
|
|
2023
Q4 | $247K | Sell |
3,333
-209,806
| -98% | -$13.8M | ﹤0.01% | 2885 |
|
|
2023
Q3 | $14.5M | Sell |
213,139
-5,097
| -2% | -$432K | 0.11% | 213 |
|
|
2023
Q2 | $20.5M | Buy |
218,236
+167,459
| +330% | +$13.1M | 0.14% | 116 |
|
|
2023
Q1 | $3.44M | Buy |
50,777
+14,423
| +40% | +$927K | 0.02% | 1235 |
|
|
2022
Q4 | $1.8M | Sell |
36,354
-45,735
| -56% | -$1.87M | 0.01% | 1944 |
|
|
2022
Q3 | $2.67M | Sell |
82,089
-46,097
| -36% | -$1.9M | 0.02% | 1704 |
|
|
2022
Q2 | $5.05M | Buy |
128,186
+6,827
| +6% | +$365K | 0.03% | 980 |
|
|
2022
Q1 | $8.48M | Buy |
121,359
+63,208
| +109% | +$4.62M | 0.07% | 379 |
|
|
2021
Q4 | $4.53M | Buy |
58,151
+45,347
| +354% | +$4M | 0.04% | 723 |
|
|
2021
Q3 | $1.22M | Buy |
12,804
+2,349
| +22% | +$248K | 0.02% | 1364 |
|
|
2021
Q2 | $1.3M | Buy |
+10,455
| New | +$1.25M | 0.01% | 1385 |
|
|
2021
Q1 | – | Sell |
-71,526
| Closed | -$9.48M | – | 2868 |
|
|
2020
Q4 | $9.48M | Buy |
71,526
+48,816
| +215% | +$5.9M | 0.13% | 175 |
|
|
2020
Q3 | $2.31M | Sell |
22,710
-2,230
| -9% | -$193K | 0.03% | 817 |
|
|
2020
Q2 | $2.17M | Buy |
+24,940
| New | +$1.99M | 0.04% | 736 |
|
|
2020
Q1 | – | Sell |
-11,823
| Closed | -$1.09M | – | 2240 |
|
|
2019
Q4 | $1.09M | Sell |
11,823
-1,657
| -12% | -$146K | 0.02% | 1104 |
|
|
2019
Q3 | $1.22M | Sell |
13,480
-79,591
| -86% | -$9.07M | 0.02% | 886 |
|
|
2019
Q2 | $11M | Buy |
93,071
+31,121
| +50% | +$3.14M | 0.2% | 100 |
|
|
2019
Q1 | $5.37M | Buy |
61,950
+56,457
| +1,028% | +$4.81M | 0.17% | 113 |
|
|
2018
Q4 | $347K | Sell |
5,493
-1,004
| -15% | -$68.9K | 0.02% | 1180 |
|
|
2018
Q3 | $513K | Sell |
6,497
-133,221
| -95% | -$8.69M | 0.03% | 812 |
|
|
2018
Q2 | $8.35M | Buy |
139,718
+127,757
| +1,068% | +$6.88M | 0.42% | 18 |
|
|
2018
Q1 | $482K | Buy |
11,961
+11,733
| +5,146% | +$572K | 0.03% | 822 |
|
|
2017
Q4 | $12K | Sell |
228
-4,048
| -95% | -$216K | ﹤0.01% | 1850 |
|
|
2017
Q3 | $201K | Buy |
4,276
+3,376
| +375% | +$136K | 0.01% | 1440 |
|
|
2017
Q2 | $32K | Buy |
+900
| New | +$27.8K | ﹤0.01% | 1584 |
|
|
2017
Q1 | – | Sell |
-2,907
| Closed | -$39K | – | 1685 |
|
|
2016
Q4 | $39K | Sell |
2,907
-38,938
| -93% | -$629K | ﹤0.01% | 1601 |
|
|
2016
Q3 | $777K | Sell |
41,845
-64,113
| -61% | -$1.13M | 0.05% | 518 |
|
|
2016
Q2 | $1.3M | Buy |
105,958
+97,299
| +1,124% | +$733K | 0.08% | 344 |
|
|
2016
Q1 | $58K | Sell |
8,659
-60,294
| -87% | -$386K | ﹤0.01% | 1461 |
|
|
2015
Q4 | $636K | Buy |
68,953
+45,757
| +197% | +$425K | 0.04% | 698 |
|
|
2015
Q3 | $417K | Buy |
23,196
+22,975
| +10,396% | +$528K | 0.02% | 1066 |
|
|
2015
Q2 | $7K | Sell |
221
-14,086
| -98% | -$354K | ﹤0.01% | 1782 |
|
|
2015
Q1 | $315K | Buy |
+14,307
| New | +$363K | 0.02% | 1229 |
|
Other funds holding EXAS
Cubist Systematic Strategies's EXAS Position: Q3 2025 in Review
Cubist Systematic Strategies reduced its Exact Sciences (EXAS) stake by 47% in Q3 2025, selling an estimated $3.63M and leaving 82,441 shares worth $4.51M. The position accounts for 0.02% of the portfolio, ranked #1024.
Cubist Systematic Strategies first reported a position in EXAS in Q1 2015 and has held it in 35 quarters since. The position peaked at $20.5M in Q2 2023. 567 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.
- Cubist Systematic Strategies held 82,441 shares of Exact Sciences worth $4.51M as of Q3 2025.
- Cubist Systematic Strategies sold 72,716 Exact Sciences shares in Q3 2025, an estimated $3.63M.
- Exact Sciences made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1024 holding.
- Cubist Systematic Strategies first reported a position in Exact Sciences in Q1 2015 and has held it in 35 quarters since.
- Cubist Systematic Strategies's Exact Sciences position peaked at $20.5M in Q2 2023.
- 567 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.